Despite data favouring a role of dietary fat in colonic carcinogenesis, no study has focused on tissue n3 and n6 fatty acid (FA) status in human colon adenoma-carcinoma sequence. Thus, FA profile was measured in plasma phospholipids of patients with colorectal cancer (n=22), sporadic adenoma (n=27), and normal colon (n= 12) (control group). Additionally, mucosal FAs were assessed in both diseased and normal mucosa of cancer (n= 15) and adenoma (n=21) patients, and from normal mucosa of controls (n=8). There were no differences in FA profile of both plasma phospholipids and normal mucosa, between adenoma and control patients. There were considerable differences, however, in FAs between diseased and paired normal mucosa of adenoma patients, with increases of linoleic (p=0.02), dihomogammalinolenic (p=0.014), and eicosapentaenoic (p=0.012) acids, and decreases of a linolenic (p=0.001) and arachidonic (p=0.02) acids in diseased mucosa. A stepwise reduction of eicosapentaenoic acid concentrations in diseased mucosa from benign adenoma to the most advanced colon cancer was seen (p=0.009). Cancer patients showed lower a linolenate (p=0.002) and higher dihomogammalinolenate (p=0.003) in diseased than in paired normal mucosa. In conclusion changes in tissue n3 and n6 FA status might participate in the early phases of the human colorectal carcinogenesis. (Gut 1996; 38: 254-259) 
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Several epidemiological studies have suggested that populations that consume high fat diets have an increased risk of colon cancer.1 The intake of saturated fat seems to account for this association, whereas an association to polyunsaturated fat intake (linoleate) has not been seen. 2 The low colon cancer rate in Alaskan Eskimos, however, has been related to the high consumption of fish products rich in n3 polyunsaturated fatty acids (n3-PUFAs),3 suggesting that fish oil may be a protective factor in colon carcinogenesis.
On the other hand, experimental studies support the idea that dietary n6-PUFAs can promote carcinogenesis. Several animal studies have shown that diets containing high proportions of n6-PUFAs increase the incidence of chemically induced colonic tumours in rats,4A6 whereas diets rich in n3-PUFAs tend to have an antipromotional effect.4 6-8 Fish oil seems to influence early stages of colon experimental carcinogenesis, with a decrease in proliferative indices and focal areas of dysplasia in azoxymethane treated rats. 9 These studies support that the fatty acid composition of the diet is more important than its overall fat content in terms of colon cancer risk. Recent data also suggest a role for PUFAs on human colon carcinogenesis. Firstly, studies on the mucosal fatty acid content in patients with colorectal carcinoma have shown increased concentrations of both arachidonic (C20:4n6) and docosahexaenoic (DHA; C22:6n3) acids in tumoral mucosa. 10 1 Nevertheless, these abnormalities could be a metabolic consequence of the established cancer rather than a causative factor for colon carcinogenesis. Secondly, n3-PUFA supplementation in healthy subjects,12 and in patients with sporadic adenomatous polyps'3 14 reduces the rate of colonic epithelial cell proliferation, thus decreasing the risk for colon cancer.15
In this study, a different approach to assess the possible role of PUFAs in the colorectal carcinogenesis processes was used. We investigated the changes of the mucosal fatty acid content in the human adenoma-carcinoma sequence, using biopsy specimens from patients with adenomas and carcinomas of the colon. Measurements were performed in both diseased and adjacent normal mucosa. The study of colorectal adenomas avoids the possible influence on PUFA metabolism of an established cancer. Fatty acid profile in plasma phospholipids was also evaluated.
Methods

Inclusion criteria
Patients who were found to specimens were obtained from suspected carcinoma lesions for histological examination. Venous blood was obtained the day after colonoscopy, before any therapeutic procedure was performed, after a 12 hour overnight fast period. Plasma was separated by centrifugation at 3000Xg for 10 minutes and was immediately stored at -20°C.
Fatty acid assay
The plasma lipid extraction procedure has been previously described.'6 Plasma phospholipids were separated by thin layer chromatography on silica gel G-60 (Merck, Darmstadt, Germany) by using the solvent system described by Skipski and Barclay. '7 Direct transesterification of fatty acids (FAs) was immediately carried out in methanol-benzene 4:1 (v/v) with acetyl chloride according to the procedure of Lepage 
Results
Nutritional status There were no significant differences in anthropometric parameters, BMI, serum proteins, and plasma vitamins between control and adenoma patients. Cancer patients, however, had significantly low values of serum albumin, prealbumin, and retinol binding protein compared with both control and adenoma groups (Table 1) .
Fatty acid concentrations in plasma phospholipids Table II describes FA concentrations in plasma phospholipids. There were no differences between control and adenoma groups. Cancer patients had significantly increased values of SFAs compared with both control and adenoma groups. In addition, both eicosapentaenoic (EPA, C20:5n3) and linoleic (C 1 8:2n6) acid concentrations and the UI were significantly lower in the cancer group.
Mucosalfatty acids Analysis of FAs could not be performed in 20% of the specimens because of technical reasons. As a consequence, about 30% of the paired comparisons could not be made. Thus, only 21 adenoma, 15 cancer, and eight control patients were included in this analysis. There were no significant differences in the clinical characteristics and FA values in plasma phospholipids between this subgroup and the whole group of patients.
Analysis of the normal looking mucosas obtained from patients with colorectal polyps and cancer showed no significant differences in the FA pattern compared with patients with normal colons. A trend was seen, however, to low EPA values in the cancer group (Table III, Fig 1) , and the arachidonate:EPA ratio was significantly increased in cancer patients (Fig 2) . As described in Table IV Fig 1) . In addition, the arachidonate:EPA ratio was significantly higher in diseased mucosa from cancer patients (mainly in Dukes's B cancer) than in diseased mucosa from benign adenoma patients (Fig 2) . A trend to low concentrations of DHA in Dukes's B and C-D cancer patients were also seen. On the other hand, the UI was significantly lower in Dukes's C-D cancer patients.
Discussion
This study shows for the first time that mucosal n3 and n6 FA status is considerably changed early in the colorectal adenoma-dysplasia-carcinoma sequence. Despite the fact that the assessment of the mucosal FA pattern could only be made in 70% of the patients, the number of cases was large enough to perform reliable statistical paired comparisons. Moreover, the subgroup of patients in whom this analysis was performed were representative of the whole series of patients, in terms of clinical features and plasma FA profile. On the other hand, interpretation of the results must be cautious as multiple statistical comparisons have been performed, a fact inherent to the studies on fatty acid status, and some of the observed significances might have arisen by chance. In this sense, only highly significant results and those with biological plausibility are discussed.
As the FA pattern in both plasma phospholipids and normal mucosa was not different between patients with either adenomatous polyps or normal colon, the observed changes in the FA status of the diseased mucosa from adenomas do not seem a consequence of differences in either fat intake or hepatic FA biosynthesis. Thus, changes of tissue lipid biochemistry might participate in the colon carcinogenesis processes. The observed changes, however, are not always readily interpretable on the basis of the present knowledge on mucosal FA metabolism. Tissue FA pattern may be the result of a combination of different phenomena including liver biosynthetic 
